Boston Trust Walden Corp boosted its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 1.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 246,351 shares of the company's stock after buying an additional 4,179 shares during the period. Chemed accounts for approximately 1.1% of Boston Trust Walden Corp's portfolio, making the stock its 13th biggest holding. Boston Trust Walden Corp owned about 1.69% of Chemed worth $151,585,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Cushing Capital Partners LLC acquired a new position in shares of Chemed in the first quarter valued at approximately $237,000. Hanson & Doremus Investment Management increased its holdings in shares of Chemed by 14.3% in the first quarter. Hanson & Doremus Investment Management now owns 3,493 shares of the company's stock valued at $2,149,000 after purchasing an additional 437 shares during the period. Everpar Advisors LLC increased its holdings in shares of Chemed by 9.0% in the first quarter. Everpar Advisors LLC now owns 485 shares of the company's stock valued at $298,000 after purchasing an additional 40 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Chemed by 8.2% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 1,496 shares of the company's stock valued at $921,000 after purchasing an additional 114 shares during the period. Finally, Net Worth Advisory Group increased its holdings in shares of Chemed by 18.1% in the first quarter. Net Worth Advisory Group now owns 541 shares of the company's stock valued at $333,000 after purchasing an additional 83 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.
Chemed Stock Up 0.2%
Shares of Chemed stock traded up $0.98 during trading on Friday, reaching $547.06. The company's stock had a trading volume of 245,728 shares, compared to its average volume of 105,026. Chemed Corporation has a 12-month low of $512.12 and a 12-month high of $623.61. The company has a market capitalization of $8.00 billion, a P/E ratio of 26.65, a price-to-earnings-growth ratio of 2.28 and a beta of 0.54. The business has a 50 day moving average price of $567.63 and a 200-day moving average price of $564.77.
Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same period in the previous year, the business earned $5.20 earnings per share. The company's revenue for the quarter was up 9.8% compared to the same quarter last year. Research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.
Chemed Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. Chemed's payout ratio is 9.74%.
Analyst Ratings Changes
CHE has been the topic of a number of recent research reports. Royal Bank Of Canada boosted their target price on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.
Read Our Latest Stock Report on CHE
Insiders Place Their Bets
In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the business's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the sale, the executive vice president now owns 14,627 shares in the company, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,500 shares of company stock worth $3,213,780. 3.29% of the stock is owned by corporate insiders.
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.